Un-audited financial results for the quarter and half year ended September 30, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 8.4 pts less than Nifty Microcap 250 and 8.2 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Multibase India, a thermoplastic compounds maker, reported Q2 FY26 revenue of Rs 1,852.76 lakhs, up about 9.5% year-on-year from Rs 1,692.74 lakhs. However, for the half year (H1 FY26), revenue fell roughly 6% to Rs 3,533.06 lakhs versus Rs 3,766.66 lakhs a year ago, indicating a weak first quarter. Net profit dropped sharply to Rs 286.28 lakhs in Q2 (from Rs 428.80 lakhs) and to Rs 516.94 lakhs in H1 (from Rs 821.07 lakhs), a decline of about 37%, mainly because other income (largely interest on surplus cash) fell to Rs 134.97 lakhs in H1 from Rs 340.23 lakhs. Basic EPS stood at Rs 2.27 for the quarter and Rs 4.09 for the half year. The statutory auditors MSKA & Associates issued a clean limited review report with no qualifications, and operating cash flow remained healthy at Rs 674.62 lakhs for the half year.
Higher finance income last year flattered the base, so the headline profit drop looks worse than the underlying business. That said, H1 revenue and operating margins did weaken, which investors should track. The Rs 5,419 lakh cash pile and Rs 378.60 lakh dividend payout continue to support the stock's appeal as a cash-rich, debt-free small-cap.